Buy Stocks Easy | About Us
September 23, 2021
Buy Stocks Easy | Online Stocks

ACST


Buy Acasti Pharma, Inc. Stock (symbol: ACST) Easy Online

Company Name: Acasti Pharma, Inc.

Symbol: ACST

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2011

ACST Current Share Price

Today's ACST ( Acasti Pharma, Inc. ) opening price: $2.6400

Yesterday's ACST ( Acasti Pharma, Inc. ) closing price: $2.5600

Acasti Pharma, Inc. Stock ( symbol: ACST ) Price Chart since IPO (2011):

12 Months Acasti Pharma, Inc. Stock ( symbol: ACST ) Price Chart

Popular Questions about Acasti Pharma, Inc. Public Stock ( ACST )

A: Acasti Pharma, Inc. stock symbol (also called stock or share ticker) is ACST

A: Acasti Pharma, Inc. IPO (Initial Public Offering) took place on 2011

A: Acasti Pharma, Inc.'s stock (ACST symbol) price at ther IPO (initial Public Offering) was $2.6400

Q: Is ACST stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Acasti Pharma, Inc. stock (symbol: ACST) at the beginning of 2019, at the opening share price of $1.0700, with a minimum of $200, by now your shares would be worth $37582 and your profit would be $37382 - SHOW ONLY IF PROFIT.

Buy Acasti Pharma, Inc. Stock Easy Online

Acasti Pharma, Inc. Stock Ticker Price Chart since IPO:





Acasti Pharma, Inc. Stock Price Yesterday



 


Acasti Pharma, Inc. Stock Price – Last Week




 


Acasti Pharma, Inc. Stock Price – Last Month




 


Acasti Pharma, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
    
ACST
5 (100%) 2 votes            
        

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/26/1952564/0/en/Acasti-Pharma-Reports-Last-Patient-Visit-in-TRILOGY-1-Phase-3-Trial-of-CaPre-for-the-Treatment-of-Severe-Hypertriglyceridemia.html
                            

                                
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia

                                
                                
On track to report topline results for TRILOGY 1 in December 2019 a...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4308236-acasti-pharma-winning-heart-race
                            

                                
Acasti Pharma - Winning The Heart Race

                                
                                
Acasti Pharma - Winning The Heart Race


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/18/1948714/0/en/Acasti-Pharma-Releases-Preliminary-New-Animal-Data-and-Gains-Insights-Into-CaPre-s-Novel-Mechanism-of-Action-in-Diabetes.html
                            

                                
Acasti Pharma Releases Preliminary New Animal Data, and Gains Insights Into CaPre’s Novel Mechanism of Action in Diabetes

                                
                                
LAVAL, Québec, Nov.  18, 2019  (GLOBE NEWSWIRE) -- Acasti Pharma In...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/04/1940324/0/en/Acasti-Pharma-Partners-with-Aker-BioMarine-to-Supply-Krill-Oil-for-CaPre.html
                            

                                
Acasti Pharma Partners with Aker BioMarine to Supply Krill Oil for CaPre®

                                
                                
Agreement provides Acasti long-term supply of raw krill oil through...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4296004-acasti-pharma-amarin-severe-hypertriglyceridemia
                            

                                
Acasti Pharma And Amarin In Severe Hypertriglyceridemia

                                
                                
The lucrative addressable market for therapeutics to treat hypertri...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/01/1923378/0/en/Acasti-Pharma-to-Present-at-the-2019-Cantor-Fitzgerald-Global-Healthcare-Conference.html
                            

                                
Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

                                
                                
LAVAL, Québec, Oct.  01, 2019  (GLOBE NEWSWIRE) -- Acasti Pharma In...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/30/1922503/0/en/Acasti-Pharma-Announces-Additional-Phase-3-Milestones-Reached-and-Remains-on-Track-to-Report-Topline-Results-for-TRILOGY-1-in-December-2019-and-TRILOGY-2-in-January-2020.html
                            

                                
Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020

                                
                                
Nearly 80% of randomized patients have completed the studies


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/09/1912754/0/en/Acasti-Pharma-Receives-Funding-from-the-Government-of-Canada-to-Expand-Production-Capacity.html
                            

                                
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity

                                
                                
LAVAL, Quebec, Sept.  09, 2019  (GLOBE NEWSWIRE) -- Acasti Pharma I...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/26/1952564/0/en/Acasti-Pharma-Reports-Last-Patient-Visit-in-TRILOGY-1-Phase-3-Trial-of-CaPre-for-the-Treatment-of-Severe-Hypertriglyceridemia.html
                            

                                
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia

                                
                                
On track to report topline results for TRILOGY 1 in December 2019 a...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4308236-acasti-pharma-winning-heart-race
                            

                                
Acasti Pharma - Winning The Heart Race

                                
                                
Acasti Pharma - Winning The Heart Race


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/18/1948714/0/en/Acasti-Pharma-Releases-Preliminary-New-Animal-Data-and-Gains-Insights-Into-CaPre-s-Novel-Mechanism-of-Action-in-Diabetes.html
                            

                                
Acasti Pharma Releases Preliminary New Animal Data, and Gains Insights Into CaPre’s Novel Mechanism of Action in Diabetes

                                
                                
LAVAL, Québec, Nov.  18, 2019  (GLOBE NEWSWIRE) -- Acasti Pharma In...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/04/1940324/0/en/Acasti-Pharma-Partners-with-Aker-BioMarine-to-Supply-Krill-Oil-for-CaPre.html
                            

                                
Acasti Pharma Partners with Aker BioMarine to Supply Krill Oil for CaPre®

                                
                                
Agreement provides Acasti long-term supply of raw krill oil through...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4296004-acasti-pharma-amarin-severe-hypertriglyceridemia
                            

                                
Acasti Pharma And Amarin In Severe Hypertriglyceridemia

                                
                                
The lucrative addressable market for therapeutics to treat hypertri...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/01/1923378/0/en/Acasti-Pharma-to-Present-at-the-2019-Cantor-Fitzgerald-Global-Healthcare-Conference.html
                            

                                
Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

                                
                                
LAVAL, Québec, Oct.  01, 2019  (GLOBE NEWSWIRE) -- Acasti Pharma In...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/30/1922503/0/en/Acasti-Pharma-Announces-Additional-Phase-3-Milestones-Reached-and-Remains-on-Track-to-Report-Topline-Results-for-TRILOGY-1-in-December-2019-and-TRILOGY-2-in-January-2020.html
                            

                                
Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020

                                
                                
Nearly 80% of randomized patients have completed the studies


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/09/1912754/0/en/Acasti-Pharma-Receives-Funding-from-the-Government-of-Canada-to-Expand-Production-Capacity.html
                            

                                
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity

                                
                                
LAVAL, Quebec, Sept.  09, 2019  (GLOBE NEWSWIRE) -- Acasti Pharma I...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.